Vaxart Inc (NASDAQ:VXRT) traded at $0.73 at close of the session on Tuesday, February 18 and made a downward move of -2.17% on its previous day’s price. Vaxart Inc has a market cap of $166.06 million and is expected to release its quarterly earnings report
The trading price of Vaxart Inc (NASDAQ:VXRT) closed lower on Friday, February 07, and closing at $0.71, -3.89% lower than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $0.7 and $0.749. In examining the 52-week
Vaxart Inc (NASDAQ:VXRT) concluded the trading at $0.72 on Wednesday, January 29 with a fall of -3.74% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $0.75 and 5Y monthly beta was
Vaxart Inc (NASDAQ:VXRT) shares, rose in value on Thursday, January 23, with the stock price down by -5.81% to the previous day’s close as strong demand from buyers drove the stock to $0.77. Actively observing the price movement in the last trading, the stock closed
Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company specializing in the discovery, development, and commercialization of oral recombinant vaccines, announced that its founder and chief scientific officer, Sean Tucker, will be giving a presentation at the upcoming World Vaccine Congress Washington on May 4-6, 2021.
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
